Medicare Advantage (MA) is a federally funded program that allows beneficiaries to enroll in plans offered by private organizations contracting with Medicare to provide Part A and Part B benefits to beneficiaries- commonly known as Part C when offered under MA- as an alternative to traditional fee-for-service Medicare. This paper examines the prevalence of enhanced cost sharing on Part B drugs in the MA market when compared to other common MA cost sharing enhancements.
This report was commissioned by PhRMA.